Free Trial

BridgeBio Pharma (BBIO) SEC Filings & 10K Form

BridgeBio Pharma logo
$22.90 -0.14 (-0.61%)
(As of 10:25 AM ET)

Recent BridgeBio Pharma SEC Filings

DateFilerForm TypeView
11/19/2024
5:06 PM
BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:13 PM
BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:15 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
3:24 PM
BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:44 AM
BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
Form SC 13G/A
11/06/2024
4:04 PM
BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
Form SC 13G/A
09/17/2024
5:44 PM
BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:41 PM
BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SC 13D/A
09/13/2024
4:04 PM
BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:16 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
7:42 PM
BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
08/20/2024
5:24 PM
BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:27 PM
BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:31 PM
BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:27 PM
BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:29 PM
BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
3:39 PM
BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:06 PM
BridgeBio Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
6:31 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
7:16 PM
BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/23/2024
3:12 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:38 PM
BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:38 PM
BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM
BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM
BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM
BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:39 PM
BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:40 PM
BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:42 PM
BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:42 PM
BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:34 PM
AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:35 PM
BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:36 PM
BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:36 PM
BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:01 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:53 PM
BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:31 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:13 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:15 PM
BridgeBio Pharma (Filer)
Form 424B5
03/04/2024
6:00 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)

One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...

02/22/2024
6:31 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
6:15 PM
BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
Form SC 13G/A
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
BridgeBio Pharma (Subject)
Form SC 13G/A
01/23/2024
9:16 AM
BridgeBio Pharma (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
3:10 PM
BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
6:30 AM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:14 PM
BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
4:33 PM
BridgeBio Pharma (Subject)
MCCORMICK FRANK (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
3:15 PM
BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:20 PM
BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
3:15 PM
BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BBIO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners